NASDAQ:CLOV

Clover Health Investments Stock News

etoro logo Buy CLOV
*Your capital is at risk
$3.65
-0.0800 (-2.14%)
At Close: Jun 03, 2026
There is no question Clover Health remains a risky proposition. However, there is one thing about CLOV stock that could make a difference.
CLOV stock has a legitimate bullish thesis to play out well over time. Meanwhile, investors have to stomach the short term shenanigans.
If you strongly believe the company's heavy losses are transitory? By all means, roll the dice with CLOV stock.

The Outlook of Clover Stock Is Deteriorating

03:19pm, Wednesday, 13'th Oct 2021
CLOV stock has been a disappointment for many reasons. Given the company's poor fundamentals, it's not worth investing in.
Today, improving investor sentiment around Clover Health and CLOV stock is driving retail investors to bid up shares of this de-SPAC play. The post CLOV Stock: What Reddit Investors Are Saying About C
Meme stocks are on the move Monday as Reddit investors watch their favorite shares rise higher amid a rally and we've got the top to watch. The post Reddit Investor Watch: 10 Biggest Meme Stock Movers
Shares of Clover Health Investments Corp (NASDAQ: CLOV) were trading 7.97% higher at $7.99 Friday afternoon.  Chamath Palihapitiya, who helped bring the health care company public through a SPAC in
Clover Health (Nasdaq: CLOV) has debuted its 2022 Medicare Advantage plans. These are the details.
CLOV stock owners should be proud to invest in a business that helps seniors get health care while also providing solid shareholder value. The post Clover Health Has Multiple Catalysts Converging to M
As fixing its profitability problem remains a work-in-progress, and as a market downturn will likely send it plummeting once more, avoiding CLOV stock is still your best move. The post The Story's Not
Clover Health Investments, Corp. (CLOV) closed at $7.39 in the latest trading session, marking a -0.2% move from the prior day.
Given the recent discouraging earnings CLOV stock possibly has a hard time ahead The post Clover Health Stock Cannot Create Shareholder Value Without Profits appeared first on InvestorPlace. More From
Clover Health stock can still see a downdraft from here despite growing revenue. CLOV stock won't likely rise until the insurer can show its Medicare business can deliver profitable medical care ratio
Traders are still hoping for another short squeeze in CLOV stock. But the odds of that happening are getting dimmer.
Clover has had a tough year despite revenue growth, stemming from pent-up demand that increased policy utilization and lower CMS risk-adjustment bonus. The company is yet to prove its disruptive busin
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE